Avi Biopharma, Inc.

Address

Avi Biopharma, Inc.
4575 Sw Research Way, Ste 200
Corvallis, OR, 97333 0106

Information

DUNS:
# of Employees: N/A

Ownership Information

Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N

Award Charts




Award Listing

  1. Apoptotic Regulation of Lymphocyte Responses

    Amount: $107,000.00

    DESCRIPTION (provided by applicant): The response of lymphocytes to antigen stimulation is characterized by proliferation of an antigen-sensitive lymphocyte population, subsequent differentiation to s ...

    SBIRPhase I2005Department of Health and Human Services
  2. Antisense Antiviral Agent for West Nile Infections

    Amount: $364,696.00

    DESCRIPTION (provided by applicant): AVI BioPharma has been developing an antisense phosphorodiamidate morpholino oligomer, AVI-4020 for the treatment of West Nile Virus. AVI-4020 has been shown both ...

    SBIRPhase I2005Department of Health and Human Services
  3. Morpholino Antisense Drugs for Hepatitis C Virus

    Amount: $164,078.00

    DESCRIPTION (provided by applicant): Hepatitis C Virus (HCV) causes a persistent infection in most humans exposed to the virus. HCV infection in time can lead to cirrhosis and hepatocellular carcinom ...

    STTRPhase I2004Department of Health and Human Services
  4. Inhibition of Androgen Receptor to treat Prostate Cancer

    Amount: $250,000.00

    DESCRIPTION (provided by applicant): Prostate cancer is the second leading cause of cancer death in US men. Prostate cancer is highly dependent on androgen stimulation mediated through the androgen ...

    SBIRPhase I2003Department of Health and Human Services
  5. Antisense Morpholino Oligomers to Treat Retinopathy

    Amount: $100,000.00

    DESCRIPTION (provided by applicant): The broad, long-term objectives of the application are to develop antisense inhibitors of retinopathy and document their mechanism(s) of action. Retinopathy is a s ...

    SBIRPhase I2003Department of Health and Human Services
  6. N/A

    Amount: $0.00

    N/A

    STTRPhase I2000Department of Health and Human Services
  7. N/A

    Amount: $424,266.00

    N/A

    STTRPhase II2000Department of Health and Human Services
  8. N/A

    Amount: $98,415.00

    N/A

    SBIRPhase I2000Department of Health and Human Services
  9. THERAPEUTIC APPLICATIONS OF PERFLUOROCARBON MICROBUBBLES

    Amount: $98,771.00

    N/A

    STTRPhase I1998Department of Health and Human Services
  10. Morpholino Antisense Drugs for Hepatitis C Virus

    Amount: $164,078.00

    DESCRIPTION (provided by applicant): Hepatitis C Virus (HCV) causes a persistent infection in most humans exposed to the virus. HCV infection in time can lead to cirrhosis and hepatocellular carcinom ...

    SBIRPhase IDepartment of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government